ADVANZ PHARMA Corp. Limited (OTCMKTS:CXRXF – Get Free Report) fell 0.7% during trading on Monday . The company traded as low as $15.51 and last traded at $17.06. 800 shares were traded during mid-day trading, a decline of 93% from the average session volume of 11,851 shares. The stock had previously closed at $17.18.
ADVANZ PHARMA Stock Performance
The company has a debt-to-equity ratio of 257.04, a quick ratio of 1.61 and a current ratio of 2.39. The firm has a market capitalization of $834.46 million and a P/E ratio of -10.28. The firm has a 50 day simple moving average of $17.06 and a two-hundred day simple moving average of $17.06.
ADVANZ PHARMA Company Profile
ADVANZ PHARMA Corp. Limited, a pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products worldwide. The company operates through two segments: ADVANZ PHARMA International and ADVANZ PHARMA North America. Its ADVANZ PHARMA International segment offers a portfolio of branded and generic prescription products to wholesalers, distributors, hospitals, and pharmacies.
Read More
- Five stocks we like better than ADVANZ PHARMA
- Investing in the High PE Growth Stocks
- Intel: Is Now the Time to Be Brave?
- Why Invest in High-Yield Dividend Stocks?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Fintech Stocks With Good 2021 Prospects
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for ADVANZ PHARMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADVANZ PHARMA and related companies with MarketBeat.com's FREE daily email newsletter.
